Foghorn Therapeutics Inc. (FHTX) Net margin 2020–2025
Foghorn Therapeutics Inc. (FHTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-240.3%FY2025 · since FY2020: -16000.0% → -240.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -240.3% | +142.9 pp |
| FY2024 | -383.2% | -95.1 pp |
| FY2023 | -288.2% | +278.1 pp |
| FY2022 | -566.3% | +7115.3 pp |
| FY2021 | -7681.6% | +8318.4 pp |
| FY2020 | -16000.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More FHTX financial trends
FHTX RevenueFHTX Net incomeFHTX Gross profitFHTX Gross marginFHTX Operating incomeFHTX Operating marginFHTX Operating cash flowFHTX Free cash flowFHTX Capital expendituresFHTX Return on equityFHTX Stock buybacksFHTX Dividends paidFHTX Total assetsFHTX Total liabilitiesFHTX Shareholders’ equityFHTX overview →